Loading...
 

SSRIs (66% of prescribed antidepressants) cause health problems - many studies


SSRI problems - Perplexity AI June 2025

Health ProblemOccurrence RateSeverity/Impact
Overall adverse events75-80%Any side effect
Sexual dysfunction25-73%Most troublesome long-term
Somnolence/Drowsiness16-59%Varies by specific SSRI
Memory impairment51%Cognitive impact
Decreased concentration50%Cognitive impact
Weight gain45-55%Long-term users
Withdrawal syndrome42.9-56%Upon discontinuation
Nausea11.9-25.7%Most common early effect
Bleeding risk increase36%Serious complication
Hyponatremia (elderly)9-39%Serious in elderly
Serotonin syndrome0.07-0.19%Rare but life-threatening

The occurrence and severity of side effects can vary significantly between different SSRIs, with paroxetine generally showing the highest rates of sexual dysfunction and weight gain, while citalopram appears to be the best-tolerated overall.

 Entire report


6+ VitaminDWiki pages have ANTIDEPRESSANT in the title

The list is automatically updated

Items found: 7

Antidepressant use and cognitive decline in patients with dementia - Feb 2025

Antidepressant use and cognitive decline in patients with dementia: a national cohort study
BMC Medicine volume 23, Article number: 82 (2025)
Minjia Mo, Tamar Abzhandadze, Minh Tuan Hoang, Simona Sacuiu, Pol Grau Jurado, Joana B. Pereira, Luana Naia, Julianna Kele, Silvia Maioli, Hong Xu, Maria Eriksdotter & Sara Garcia-Ptacek

Background
Dementia is associated with psychiatric symptoms but the effects of antidepressants on cognitive function in dementia are understudied. We aimed to investigate the association between antidepressants and cognitive decline in patients with dementia, and the risk of severe dementia, fractures and death, depending on antidepressant class, drug, and dose.

Methods
This is a national cohort study. Patients with dementia registered in the Swedish Registry for Cognitive/Dementia Disorders-SveDem from May 1, 2007, until October 16, 2018, with at least one follow-up after dementia diagnosis, and who were new users of antidepressants, were included. Antidepressant use as a time varying exposure defined during the 6 months leading up to dementia diagnosis or each subsequent follow-up. We used linear mixed models to examine the association between antidepressant use and cognitive trajectories assessed by Mini-Mental State Examination (MMSE) scores. We used Cox proportional hazards models to calculate the hazard ratios for severe dementia (MMSE score < 10), fracture, and death. We compared antidepressant classes and drugs, and analyzed dose–response.

Results
We included 18740 patients (10 205 women [54.5%]; mean [SD] age, 78.2 [7.4] years), of which 4271 (22.8%) received at least one prescription for an antidepressant. During follow-up, a total of 11912 prescriptions for antidepressants were issued, with selective serotonin reuptake inhibitors (SSRI) being the most common (64.8%).
Antidepressant use was associated with

  • faster cognitive decline (β (95% CI) = − 0.30(− 0.39, − 0.21) points/year),
    • in particular sertraline (− 0.25(− 0.43, − 0.06) points/year),
    • citalopram (− 0.41(− 0.55, − 0.27) points/year),
    • escitalopram (− 0.76(− 1.09, − 0.44) points/year), and
    • mirtazapine (− 0.19(− 0.34, − 0.04) points/year) compared with non-use.

The association was stronger in patients with severe dementia (initial MMSE scores 0–9). Escitalopram showed a greater decline rate than sertraline. Compared with non-use, dose response of SSRIs on greater cognitive decline and higher risks of severe dementia, all-cause mortality, and fracture were observed.

Conclusions
In this cohort study, current antidepressant use was associated with faster cognitive decline; furthermore, higher dispensed doses of SSRIs were associated with higher risk for severe dementia, fractures, and all-cause mortality. These findings highlight the significance of careful and regular monitoring to assess the risks and benefits of different antidepressants use in patients with dementia.
 Download the PDF from VitaminDWiki


>100 SSRI problems (including the Feb 2025 study) GreenMedInfo June 2025

SSRI Shockwave: New Study Ties Antidepressants to Faster Cognitive Decline, Fractures, and Early Death


SSRI Drugs Can Cause Chronic Fatigue Syndrome - Mercola April 2024

Mercola April 2024

STORY AT-A-GLANCE

  • SSRIs, which increase serotonin levels, have been linked to chronic fatigue syndrome (CFS). A study showed that administering Prozac (fluoxetine) to mice at high dosages induced symptoms of CFS, suggesting a link between excessive serotonin levels and the condition
  • Symptom reversal was achieved with the serotonin inhibitor fenclonine
  • Other serotonin inhibitors include Benadryl, the H2 blocker Pepcid (famotidine), aspirin, progesterone and GABA
  • Branched-chain amino acids, tyrosine, phenylalanine and L-theanine can also help reduce serotonin levels
  • GABA is a more effective solution for conditions typically treated with SSRIs, such as depression and anxiety, without the adverse effects associated with elevated serotonin
  • Reducing intake of linoleic acid (LA), found in high amounts in seed oils and certain meats, is recommended if you have CFS, as excess LA impair your mitochondrial function and cellular energy production
    • Note: LAs reduces the Omage-3

 Download the PDF from VitaminDWiki


Some SSRIs (fluoxetine) inhibit CYP27A1, thus reducing Vitamin D

Perplexity AI April 2024
The specific SSRIs that have been noted to inhibit CYP27A1 include citalopram, fluoxetine, and sertraline17. This inhibition can lead to drug-drug interactions, particularly in patients who are on multiple medications, as CYP27A1 plays a role in the metabolism of various substances1417.

VitaminDWiki - Genetics chart shows the vitamin D genes
in Visio for 2023


VitaminDWiki – Depression substantially reduced by Vitamin D, Omega-3, Magnesium, etc – many studies


VitaminDWiki – Depression has many antidepressant entries

2X increase in risk if Sudden Cardiac Death if take antidepressent drugs for > 6 years - April 2025
The Hidden Dangers of Antidepressants and Why It's So Hard to Stop Taking Them - Feb 2025
Just How Far Will the FDA Go To Protect A Bad Drug? (SSRI ) - Dec 2023
37% of Americans take drugs that list depression as a possible side effect - July 2023
A decade of use of antidepressive drugs doubles CVD - Oct 2022
SSRIs cause long term sexual dysfunction (prescription warnings in Europe and Canada)
Why Are Antidepressants (SSRIs) so Harmful? - Nov 2023
Antidepressant drugs often not effective and hard to stop using - Oct 2022


VitaminDWiki – Overview Fibromyalgia or Chronic Fatigue and vitamin D